Criminal Story of a Prevention - Ukrainian Anti Cancer Institute

Harassment from All Sides
The year 1993 brought international cancer research trail-blazing new evidence about
the cancer process. In studies of cell death and ‘programmed cell death’ within cells,
American and Australian scientists gained a completely new insight into understanding this
insidious disease. According to them, cells have an inner clock which tells them when they
must die. In cancer this clock does not seem to work, whereby the life of the cells is
prolonged and the life of the carrier of these cells is put at risk. The cancer runs its course. It
had already been known for a long time that in the development of embryos certain cells are
programmed to die at a certain time. The researchers now discovered that this phenomenon
was not confined to the development of embryos. In medical terminology this programmed
cell death (PCD) is called apoptosis, a Greek expression for leaves falling from a tree or a
plant.
In 1993 these new findings were published in the renowned American journal
‘Science’. At the time, cancer researchers throughout the world tried to find a substance
which would force cancer cells to carry out the ‘suicide’ order. The first to find one was
Professor Liepins at the Memorial University in St. John’s, Canada. At the 11 th
Interdisciplinary World Congress in Geneva he reported on his experiments with Ukrain as an
agent of cell death at a session dedicated to Ukrain with a total of nine papers delivered. He
had demonstrated in laboratory experiments that the alkaloid derivative from greater
celandine, Ukrain, caused characteristic programmed cell death.
With the exception of Nowicky, not a single Austrian was represented at the congress
as a speaker. Austrian cancer specialists stayed away from this session. The fact that they
continued to ignore this drug, which had been developed in Austria, can be explained in no
other way.
For years. Ukrain had been discussed at all international cancer congresses (far more
than 100). Nowicky had been expressly invited to most of them including the 20 th
International Congress of Chemotherapy from 29 June to 3 July 1997 in Sydney, Australia,
where eleven speakers presented their results with Ukrain at a special session. Nowicky
reported on a clinical study carried out in Poland in which Ukrain had been used to cause cell
death in patients suffering from breast cancer. Even at the low dose of only 50 mg, Ukrain
caused cell death in cancer cells. The number of cells which reacted was dependent on the
malignancy of the cancer.
In 1993 the connection was made between cancer and programmed cell death. In April
1994 in Geneva, Ukrain was reported to be the trigger to bring about the death of cells which
had refused to die. In June 1993 the Austrian Ministry of Health had given approval for
clinical studies on the basis of a report from the drugs commission. In June 1994 the same
ministry wrote to the regional health insurance authorities in Upper Austria (‘Re: Use of
Ukrain’) referring to a ‘general ban on the use of Ukrain due to a decree of the federal
ministry of 25 July 1986 - although this ban had not been binding for a long time on purely
formal grounds (there was no confirmation).
It went on, ‘Until now, no definitive, state-of-the-art evidence of efficacy has been
brought forward for the substance Ukrain.’ Furthermore, it was also pointed out that the list of
publications given to the health insurance authorities included publications which had also
been given to the drugs commission for assessment. Why this fact should be detrimental was
not explained. ‘Therefore,’ continued the letter with incestuous logic, ‘it is still not
scientifically proven that the substance Ukrain can achieve the above-mentioned ‘success’.’ It
also did not fail to refer to the fact that if Ukrain was administered outside the framework of a
clinical study, a fine of ‘up to € 72,000’ was threatened.
33